13.200
+0,00%
2026-07-31
Fundamental Analysis
78 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +165.6% | +39.0% | 1 / 3 | +60.8% | +4.11 pp | +6.76 pp | +6.4% | 0.00 | 14.04 | 14,3 | +60,8% | 2,4 | +165,6% | 14.04 | 27.30 | −48,6% |
| Pts | 12 | 8 | 4 | 12 | 12 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 13.200 (close price on 2026-07-31)EPS (TTM): 940,3
Financial charts
1.Revenue & growth
VND bn14,3Q2/26
1.Revenue & growth
VND bn14,3Q2/26
2.Profit & growth
VND bn-0,33Q2/26
3.Profit mix (Penman)
VND bn2,34Q2/26
4.Margins & cost structure
%16.9%Q2/26
5.Returns & cash cycle
% · days2.4%Q2/26
6.Earnings quality & cash
VND bn8,67Q2/26
7.Asset structure
VND bn85,7Q2/26
8.Funding & debt health
VND bn · times85,7Q2/26
9.Revenue backlog
VND bn0,13Q2/26
10.Valuation
times · %34,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-66Q2/26
Adjusted EPS growth, latest quarter
-136%
Average adjusted EPS growth, 3 quarters
-61.6%
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26